Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly oo leh kiimoterabi waxa ay FDA u ansixisay kansarka endometrial
Agoosto 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), oo ay ku xigto dostarlimab-gxly oo ah wakiil keli ah, waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee daawaynta kansarka endometrial aasaasiga ah ama soo noqnoqda (EC..
dMMR, Dostarlimab-gxly, GlaxoSmithKline, Jemperli
Dostarlimab-gxly waxay FDA u ansixisay kansarka endometrial dMMR
Feb 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) waxaa la siiyay ogolaanshaha FDA si loogu daweeyo bukaanada qaangaarka ah ee qaba cillad la'aanta dayactirka (dMMR) ee soo noqnoqda ama sare u kaca kansarka endometrial kaas oo horumaray intii lagu jiray ama ka dib.
dostarlimab, Gina Kolata, GlaxoSmithKline, Luis A. Diaz Jr, NEJM
Dhammaan ka qaybgalayaasha tijaabada kansarka yar waxay heleen cafis dhammaystiran
Juun 2022: Daraasad yar oo lagu sameeyay bukaannada kansarka malawadka ayaa keenay natiijooyin aan caadi ahayn: 100 boqolkiiba shakhsiyaadka ayaa ku jiray cafis. Natiijooyinka waxaa lagu daabacay wargeyska New England Journal of Medicine todobaadkan. Tijaabada waxaa la maalgeliyay ..